Skip to main content

Fosamax Plus D FDA Approval History

FDA Approved: Yes (First approved April 7, 2005)
Brand name: Fosamax Plus D
Generic name: alendronate and cholecalciferol
Dosage form: Tablets
Company: Merck & Co., Inc.
Treatment for: Osteoporosis

Fosamax Plus D is a single once-weekly tablet containing the bisphosphonate drug alendronate, and seven days’ worth of vitamin D, an essential nutrient required for calcium absorption. Fosamax Plus D is used to reduce the risk of hip and spinal fractures in postmenopausal women with osteoporosis, and to increase bone mass in men with osteoporosis.

Development timeline for Fosamax Plus D

Apr  7, 2005Approval Fosamax Plus D Merck & Co., Inc. - Treatment for Osteoporosis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.